Eurobio Scientific SA (ALERS) — Cash Flow-to-Debt Ratio
Eurobio Scientific SA (ALERS) has a Cash Flow-to-Debt Ratio of 0.07x as of June 2025, meaning its operating cash flow of €5.36 Million could theoretically repay 0% of its total liabilities (€78.26 Million) in one year. See Eurobio Scientific SA free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Eurobio Scientific SA Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for Eurobio Scientific SA across 18 annual periods. Also explore ALERS net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Eurobio Scientific SA (2007–2024)
Year-by-year debt coverage analysis for Eurobio Scientific SA. For market capitalisation and broader financial context, see ALERS market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.21x | €16.70 Million | €78.31 Million | ▲ +12.5% |
| 2023 | 0.19x | €26.77 Million | €141.16 Million | ▼ -30.6% |
| 2022 | 0.27x | €43.07 Million | €157.75 Million | ▼ -79.7% |
| 2021 | 1.35x | €65.92 Million | €49.00 Million | ▲ +57.8% |
| 2020 | 0.85x | €54.93 Million | €64.45 Million | ▲ +659.0% |
| 2019 | 0.11x | €4.99 Million | €44.44 Million | ▲ +964.7% |
| 2018 | -0.01x | €-523.00K | €40.27 Million | ▼ -120.9% |
| 2017 | 0.06x | €2.48 Million | €39.88 Million | ▲ +136.8% |
| 2016 | -0.17x | €-3.32 Million | €19.66 Million | ▲ +14.4% |
| 2015 | -0.20x | €-2.44 Million | €12.40 Million | ▲ +26.9% |
| 2014 | -0.27x | €-3.38 Million | €12.55 Million | ▲ +29.3% |
| 2013 | -0.38x | €-4.90 Million | €12.85 Million | ▼ -20.0% |
| 2012 | -0.32x | €-4.45 Million | €13.99 Million | ▲ +78.7% |
| 2011 | -1.49x | €-6.02 Million | €4.04 Million | ▼ -210.4% |
| 2010 | -0.48x | €-5.80 Million | €12.07 Million | ▲ +20.5% |
| 2009 | -0.60x | €-6.71 Million | €11.09 Million | ▼ -26.4% |
| 2008 | -0.48x | €-9.62 Million | €20.11 Million | ▼ -89.3% |
| 2007 | -0.25x | €-4.93 Million | €19.52 Million | — |